Jery Inbarasu, MD
Interventional Pain Medicine · Omaha, NENPI 1538548300
Payments from drug & device makers
What this record shows
It is spread thinly across 22 manufacturers, the largest accounting for just 18.2%. Reporting peaked in 2022 at $5,385 and has fallen 89.4% since, to $573 in 2025.
Across 186 payments — averaging $63.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Boston Scientific$2K
- Abbott$2K
- Spinal Simplicity, LLC$1K
- Relievant Medsystems, Inc.$1K
- SPR Therapeutics, Inc$869
- plus $2K from 16 others
What the payments were for
- Travel & lodging$6,06251%
- Food & beverage$5,81449%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 20 | $2,162 |
| Boston Scientific | 58 | $2,132 |
| Abbott | 17 | $2,049 |
| Spinal Simplicity, LLC | 8 | $1,402 |
| Relievant Medsystems, Inc. | 10 | $1,089 |
| SPR Therapeutics, Inc | 8 | $869 |
| Nalu Medical, Inc. | 8 | $625 |
| Nevro Corp. | 9 | $530 |
| AbbVie | 14 | $277 |
| Si-bone, Inc. | 6 | $164 |
| Johnson & Johnson | 5 | $118 |
| Biotronik NRO, Inc. | 4 | $99 |
| Lilly USA, LLC | 5 | $85 |
| Tersera Therapeutics LLC | 2 | $63 |
| Forte Bio-pharma LLC | 4 | $46 |
| Bioventus LLC | 1 | $42 |
| Azurity Pharmaceuticals, Inc. | 2 | $35 |
| Baudax Bio Inc. | 1 | $23 |
| Merz Pharmaceuticals, LLC | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| Microtransponder, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$3,677
- HA MINUTEMAN G3-R$1,306
- INTELLIS$1,109
- Superion Indirect Decompression System$1,088
- PROCLAIM$970
- Axium$710
- SPRINT PNS System$582
- INTELLIS ADAPTIVESTIM$271
- Senza Spinal Cord Stimulation System$241
- Nalu Neurostimulation System$224
- VANTA ADAPTIVESTIM$200
- SYNCHROMED$145
- WaveWriter Alpha Prime 16$143
- Proclaim IPG$121
How this compares
Too few interventional pain medicine providers in Nebraskato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 21 | $6,060 |
| Pregabalin | 175 | $3,579 |
| Gabapentin | 185 | $2,360 |
| Duloxetine Hcl | 127 | $2,202 |
| Celecoxib | 57 | $1,280 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 59 | $1,167 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $1,004 |
| Baclofen | 43 | $889 |
| Lidocaine | 13 | $834 |
| Morphine Sulfate ErMorphine Sulfate | 15 | $666 |
| Tizanidine Hcl | 44 | $499 |
| Tramadol Hcl | 108 | $387 |
| Methocarbamol | 15 | $312 |
| Cyclobenzaprine Hcl | 33 | $225 |
| Nortriptyline Hcl | 14 | $184 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Omaha
- Rafal KrejzaOmaha$13K
- Kevin BalterOmaha$11K
- Madhuri AreOmaha$904
- Soubrata RaikarFremont$38K
- Clayton DammeLincoln$21K
- Pravardhan BirthiGrand Island$19K
- Kelly ZachLincoln$15K
- Thomas BrooksElkhorn$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.